The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension
- DOI
- 10.1016/j.ejphar.2026.179227
- Published
- 2026-10
- Container
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179227,
title = {The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension},
author = {Aoxue Yuan and Yaqian Bai and Yuanhang Jiang and Shengnan Si and Pengwei Wang and Fanrong Zhao and Yujing Chen and Tiantian Zhu},
year = {2026},
journal = {European Journal of Pharmacology},
doi = {10.1016/j.ejphar.2026.179227},
url = {https://doi.org/10.1016/j.ejphar.2026.179227}
}RIS
TY - JOUR TI - The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension AU - Aoxue Yuan AU - Yaqian Bai AU - Yuanhang Jiang AU - Shengnan Si AU - Pengwei Wang AU - Fanrong Zhao AU - Yujing Chen AU - Tiantian Zhu PY - 2026 JO - European Journal of Pharmacology DO - 10.1016/j.ejphar.2026.179227 UR - https://doi.org/10.1016/j.ejphar.2026.179227 ER -
APA
Yuan, A., Bai, Y., Jiang, Y., Si, S., Wang, P., Zhao, F., Chen, Y., & Zhu, T. (2026). The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.179227
Source records
- crossref · retrieved 2026-09-26T09:40:46.006Z